Retail buzz, consumer evidence: the omnichannel gap

Consumers want proof it works, not proof it's everywhere

Across 11 categories — including Functional Mushrooms, Gut Health & Microbiome, Longevity & Cellular Health, Women's Health, Nootropics & Cognitive, and Energy & Performance — consumer signals converge on one demand: tangible, noticeable results. Consumer evidence favors named outcomes over general wellness language.

→ If your consumer-facing launch story leads with availability, it is answering where to buy rather than whether it works.

SOURCE: Cross-category synthesis — STRONG

Safety questions are a quiet drag on three high-growth categories

Across Adaptogens & Stress Support, Nootropics & Cognitive, and Functional Botanicals, consumers describe recurring side-effect concerns in their own words — lightheadedness, dizziness, increased TSH. These are consumer-reported experiences, not established category-wide effects, but they recur across three categories often enough to constitute a live communication gap.

→ There is room to differentiate on purity, dosage transparency and contraindication guidance — on product pages, education and supporting pack copy, where there is space to be specific. Any dosage or contraindication language should clear regulatory review first.

SOURCE: Cross-category synthesis — MODERATE

Targeted Wellness carries the strongest consumer evidence

With 200 of 328 signals originating from consumers, Targeted Wellness for Specific Needs carries the strongest concentration of consumer-originated evidence in the June 17–August 16 pulse. Stress, sleep, cognitive function, and women's health are driving specificity of ingredient demand — adaptogens, functional mushrooms, inositol, berberine.

→ General-wellness formulations are more exposed to price comparison; named-outcome formulations have more room to compete through relevance and identity.

SOURCE: Aterra Gravity Trend Pulse — 328 signals (200 consumer)

"Energy" spans 13 categories — the widest footprint in the feed

The keyword "energy" surfaces across 13 distinct categories, from Longevity & Cellular Health to Kids & Family Nutrition to Anti-Inflammatory & Metabolic — no other keyword in this cycle matches that reach. When a single word appears in categories with no shared consumer profile, it has crossed from ingredient claim into platform language.

→ An energy benefit can be credibly anchored in more category contexts than a sleep or stress benefit — which is formulation and positioning optionality, not a guarantee of a larger audience.

SOURCE: Cross-category convergence — 13 categories

"Sleep," "stress," and "gut" each span 9 categories — and overlap in three

All three keywords appear across 9 categories each, and three categories carry all three at once: Women's Health, Nootropics & Cognitive, and Sleep & Recovery. Shoppers in those three categories are likely to encounter all three claim families.

→ Formulations or marketing that bundle two or more of these axes (stress + sleep, gut + mood) are not trend-chasing — they match vocabulary that recurs across the consumer evidence in those categories.

SOURCE: Cross-category convergence — 9 categories

Longevity's founding vocabulary is being replaced, not abandoned

In Longevity & Cellular Health, "Anti-Aging" rose from 12% to 21% of observed claim mass between the June 20 and August 15 Amazon shelf snapshots, while "Longevity" fell from 21% to 10% and "Healthy Aging" from 23% to 13%. The direction survives a second measure — mentions per product — but the snapshots sampled 20 and 60 products per category, so this is a watch item, not a finding.

→ A vocabulary reset rather than a category contraction: a copy and claim-hierarchy update could close a positioning gap faster than any reformulation. Anti-Aging appeared on 5 of 20 products in June, so the direction is the finding and the magnitude is approximate.

SOURCE: Amazon shelf snapshots — Jun 20 (n=20/category) vs Aug 15 (n=60/category)

P&G's $3.8B acquisition of Thorne is competitive confirmation, not consumer confirmation

Procter & Gamble announced it will acquire supplement brand Thorne for $3.8 billion — one of the world's largest consumer-goods companies allocating capital into the space where consumer-originated evidence is most concentrated. But capital conviction and consumer validation are different things, and this evidences the first.

→ Treat it as a competitive clock, not a demand proof: a category carrying concentrated consumer evidence now has a strategic buyer in it, and the window before competition intensifies is narrower than it was.

SOURCE: eMarketer

Functional beverage distribution is moving ahead of confirmed pull-through

Juni debuted in 600+ Albertsons Companies stores across California, bringing its total nationwide footprint — across Whole Foods, Costco, Target, Kroger, Albertsons, Sprouts and others — to over 8,500 doors. Functional Beverages as a theme carries only 32% consumer origination across 140 signals.

→ The press-heavy signal mix makes Juni a useful test of whether rapid distribution converts into sustained pull-through. Door count alone cannot answer that — velocity and repurchase can.

SOURCE: BevNET

A retailer invests in the last step of the path to purchase

Ahold Delhaize USA partnered with Pear Commerce so shoppers can add products to carts directly from brand pages, recipe content and store locators across five banners.

→ Reducing path-to-purchase friction is becoming a retailer priority alongside distribution and awareness. For brands already in mass or grocery, shoppable content is worth evaluating against additional door growth.

SOURCE: eMarketer

Three things to do with this

1 — Measure velocity and repurchase by SKU and channel, not door count. Availability is the input you already control, and the one your press coverage already reflects. 2 — Test a named-outcome claim against your broad wellness language on the same SKU: the efficacy pattern spans 11 categories, and general language is not what consumers are describing. 3 — If you sell in adaptogens, nootropics or functional botanicals, audit your safety, dosage and contraindication communication. Those concerns are already in consumer language and largely unanswered on pack.

→ Door count creates availability. Noticeable outcomes create velocity and repurchase. This issue can tell you where the evidence is concentrated; only your own sell-through can tell you whether the doors are working.

Three definitions — and one limit we are publishing anyway

A signal is one dated, classified entry in the feed, sampled across a rolling 60-day window, round-robin over capture date and category so no single scrape batch can dominate a theme. Consumer-originated means a shopper speaking for themselves: reviews, forums, social, video comments — a creator explaining an ingredient counts as press, not consumer. Note that consumer-origin share describes the composition of the evidence, not the strength of demand: themes differ in how naturally consumers speak about them, and nobody discusses their own life in the language of omnichannel distribution.

→ The limit: this cycle's two shelf snapshots sampled 20 and 60 products per category, so they are not a matched universe and a claim's share can move because the frame changed rather than because the shelf did. We re-checked every movement as mentions per product to reduce the effect of sample depth, though the unmatched product universe remains a limitation. Two of the three movements we had drafted did not survive that check and were dropped. The next snapshot is matched at 60 products, and this section returns to full strength then.

SOURCE: Aterra Gravity methodology — gravity.aterrastudio.co/methodology